Cargando…

Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression

BACKGROUND: BK nephropathy (BKN) affects graft function and increases the risk of graft failure. The reduction of immunosuppression is the main treatment for BKN. However, acute rejection may develop following immunosuppression reduction, and data regarding the risk factors of acute rejection during...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Chung Hee, Kim, Hyosang, Yu, Hoon, Yang, Won Seok, Han, Duck Jong, Park, Su-Kil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248279/
https://www.ncbi.nlm.nih.gov/pubmed/30297686
http://dx.doi.org/10.12659/AOT.910483
_version_ 1783372609832878080
author Baek, Chung Hee
Kim, Hyosang
Yu, Hoon
Yang, Won Seok
Han, Duck Jong
Park, Su-Kil
author_facet Baek, Chung Hee
Kim, Hyosang
Yu, Hoon
Yang, Won Seok
Han, Duck Jong
Park, Su-Kil
author_sort Baek, Chung Hee
collection PubMed
description BACKGROUND: BK nephropathy (BKN) affects graft function and increases the risk of graft failure. The reduction of immunosuppression is the main treatment for BKN. However, acute rejection may develop following immunosuppression reduction, and data regarding the risk factors of acute rejection during the post-reduction period are insufficient. MATERIAL/METHODS: Of 758 patients who received a kidney transplantation (KT) between 2008 and 2011, 79 who underwent immunosuppression reduction as BKN treatment were enrolled. The risk factors of acute rejection after immunosuppression reduction were identified using multivariate logistic regression analysis. RESULTS: During the median follow-up period (75 months), acute rejection developed in 21.5% of study group patients and in 22.5% of KT recipients without BKN. The rejection group showed a trend of higher body mass index (24.13±3.92 vs. 22.40±3.31 kg/m(2), P=0.070) and lower tacrolimus levels than the no rejection group, although mycophenolate mofetil (MMF) doses were not lower in the rejection group. The rejection group showed worse graft survival than the no rejection group (P=0.001 by the log rank test). A greater number of patients in the rejection group exhibited reduced calcineurin inhibitor (CNI) level by >20% at 1 month after initial BKV detection (34.2% vs. 7.9%, P=0.008). Multivariate analysis indicated that the peak BKV PCR level (odds ratio [OR], 0.136; 95% confidence interval [CI], 0.025–0.732; P=0.020), MMF discontinuation (vs. MMF reduction; OR, 0.112; 95% CI, 0.020–0.618; P=0.012) and CNI level reduction >20% (OR, 33.752; 95% CI, 4.263–267.251; P=0.001) were significantly associated with acute rejection. CONCLUSIONS: Acute rejection after immunosuppression reduction for BKN showed worse allograft survival than the patients without acute rejection. In addition, a CNI dose reduction >20% at 1 month after the initial BKV detection can increase the risk of acute rejection.
format Online
Article
Text
id pubmed-6248279
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-62482792018-11-28 Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression Baek, Chung Hee Kim, Hyosang Yu, Hoon Yang, Won Seok Han, Duck Jong Park, Su-Kil Ann Transplant Original Paper BACKGROUND: BK nephropathy (BKN) affects graft function and increases the risk of graft failure. The reduction of immunosuppression is the main treatment for BKN. However, acute rejection may develop following immunosuppression reduction, and data regarding the risk factors of acute rejection during the post-reduction period are insufficient. MATERIAL/METHODS: Of 758 patients who received a kidney transplantation (KT) between 2008 and 2011, 79 who underwent immunosuppression reduction as BKN treatment were enrolled. The risk factors of acute rejection after immunosuppression reduction were identified using multivariate logistic regression analysis. RESULTS: During the median follow-up period (75 months), acute rejection developed in 21.5% of study group patients and in 22.5% of KT recipients without BKN. The rejection group showed a trend of higher body mass index (24.13±3.92 vs. 22.40±3.31 kg/m(2), P=0.070) and lower tacrolimus levels than the no rejection group, although mycophenolate mofetil (MMF) doses were not lower in the rejection group. The rejection group showed worse graft survival than the no rejection group (P=0.001 by the log rank test). A greater number of patients in the rejection group exhibited reduced calcineurin inhibitor (CNI) level by >20% at 1 month after initial BKV detection (34.2% vs. 7.9%, P=0.008). Multivariate analysis indicated that the peak BKV PCR level (odds ratio [OR], 0.136; 95% confidence interval [CI], 0.025–0.732; P=0.020), MMF discontinuation (vs. MMF reduction; OR, 0.112; 95% CI, 0.020–0.618; P=0.012) and CNI level reduction >20% (OR, 33.752; 95% CI, 4.263–267.251; P=0.001) were significantly associated with acute rejection. CONCLUSIONS: Acute rejection after immunosuppression reduction for BKN showed worse allograft survival than the patients without acute rejection. In addition, a CNI dose reduction >20% at 1 month after the initial BKV detection can increase the risk of acute rejection. International Scientific Literature, Inc. 2018-10-09 /pmc/articles/PMC6248279/ /pubmed/30297686 http://dx.doi.org/10.12659/AOT.910483 Text en © Ann Transplant, 2018 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Original Paper
Baek, Chung Hee
Kim, Hyosang
Yu, Hoon
Yang, Won Seok
Han, Duck Jong
Park, Su-Kil
Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression
title Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression
title_full Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression
title_fullStr Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression
title_full_unstemmed Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression
title_short Risk Factors of Acute Rejection in Patients with BK Nephropathy After Reduction of Immunosuppression
title_sort risk factors of acute rejection in patients with bk nephropathy after reduction of immunosuppression
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248279/
https://www.ncbi.nlm.nih.gov/pubmed/30297686
http://dx.doi.org/10.12659/AOT.910483
work_keys_str_mv AT baekchunghee riskfactorsofacuterejectioninpatientswithbknephropathyafterreductionofimmunosuppression
AT kimhyosang riskfactorsofacuterejectioninpatientswithbknephropathyafterreductionofimmunosuppression
AT yuhoon riskfactorsofacuterejectioninpatientswithbknephropathyafterreductionofimmunosuppression
AT yangwonseok riskfactorsofacuterejectioninpatientswithbknephropathyafterreductionofimmunosuppression
AT handuckjong riskfactorsofacuterejectioninpatientswithbknephropathyafterreductionofimmunosuppression
AT parksukil riskfactorsofacuterejectioninpatientswithbknephropathyafterreductionofimmunosuppression